⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 3, 2026

Pramipexol Actavis 0,18 mg Tabletten 0,18 mg (Tablette)

📷 Wikipedia: Pramipexole · Source
Pramipexol Actavis 0,18 mg Tabletten 0,18 mg (Tablette)
📷 Wikipedia: Pramipexole · Source
Pramipexole Actavis 0.18 mg tablets are currently unavailable due to a manufacturing delay. Parallel export is prohibited.
⚠️
Shortage ongoing
PRAMIPEXOL DIHYDROCHLORID MONOHYDRAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Pramipexol is a medicine used for Parkinson’s disease or restless legs. It comes as small white tablets.

What's happening? The 0.18 mg tablets are out of stock in Austria. The company cannot make them right now.

Does this affect me? If you take this exact strength in Austria, you may not find it at the pharmacy.

What should I do? Ask your pharmacist or doctor for another strength or brand that works for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: N04BC05 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-27] · 100 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-03-24]

First published
April 3, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT resolved 1 month ago

Pramipexol ratiopharm 0,52 mg Retardtabletten 0,52 mg (Retardtablette)

Pramipexole ratiopharm 0.52 mg prolonged-release tablets are delayed in supply.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Pramipexol Actavis 0,18 mg Tabletten 0,18 mg (Tablette). Pramipexole Actavis 0.18 mg tablets are currently unavailable due to a manufacturing delay. Parallel export is prohibited.
▸ When was this alert issued?
This alert was issued on April 3, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.